Am Orthopt J  48: 39-46  (1998).

Richard G. Scobee Memorial Lecture
What Does the Future Hold for Amblyopia Therapy?

Malcolm L. Mazow, M.D.

Since physicians first became aware of strabismus, ophthalmologists have known that the visual loss occurred as a result of ocular deprivation arresting cortical development. This is manifested as a monocular visual decrease, a binocular sensory deficiency, and/or total absence of binocular cooperation. This paper will highlight the present management of amblyopia, including prevention and current therapy techniques. Emphasis will be placed on new treatment areas and speculation on their future roles in the correction and prevention of this major health problem. Other issues to be addressed include the likelihood of genetic engineering in the future management of amblyopia and in today's medical health management environment and how outcome studies will impact the practice of pediatric ophthalmic care in the management of amblyopia.

© 1998 The Board of Regents of the University of Wisconsin System